Top Markets
Coin of the day
Welgene Biotech Co.,Ltd. Welgene Biotech Co.,Ltd.

Welgene Biotech Co.,Ltd.

6661
Clasificación en acciones #31675
Welgene Biotech Co.,Ltd. primarily focuses on delivering genetic analysis... Welgene Biotech Co.,Ltd. primarily focuses on delivering genetic analysis services. The company provides comprehensive support for scientific research, employing a range of advanced laboratory techniques such as genetic sequencing, microarray analysis, qPCR verification, nucleic acid extraction and quality control, LCM single cell experimentation, and intricate bioinformatics analysis. A key offering in their portfolio is Cytoscan, an array-based comparative genomic hybridization (CGH) solution. Beyond services, Welgene Biotech also supplies essential laboratory products, including various reagents, consumable items, and specialized instruments, alongside dedicated software solutions. Established in 2003, the company operates from its headquarters in Taipei City, Taiwan.
Precio por acción
$0.53422367
Capitalización bursátil
$12.45M
Cambio (1 día)
0.30%
Cambio (1 año)
-19.98%
País
TW
Comercio Welgene Biotech Co.,Ltd. (6661)

Categoría

Ganancias de Welgene Biotech Co.,Ltd. (6661)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Welgene Biotech Co.,Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Welgene Biotech Co.,Ltd. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$7.61B -
US
$4.76B -
US
- -
CN
$-252.70M -
US
$1.42B -
US